Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Drugs Used in Lower Respiratory Disorders: Overview
Asthma III: Clinical Manifestations
Asthma-IV: Diagnostic and Management
Asthma I: Introduction
Allergic Reactions: Anaphylaxis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 18, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
M L Barnes1, S Vaidyanathan, P A Williamson
1Asthma & Allergy Research Group, Department of Medicine and Therapeutics, Ninewells Hospital & Medical School, University of Dundee, Scotland, UK. mr.mlbarnes@gmail.com
This study calculated the minimal clinically important difference (MCID) for allergic rhinitis (AR) outcomes. MCIDs for quality of life, nasal airflow, and symptom scores were determined, aiding clinical interpretation of research findings.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: